Selected research
Industry Research
Custom Assay Development Industry Research Report 2026
Market perspective
The global Custom Assay Development market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Custom Assay Development market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Custom Assay Development market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Custom Assay Development market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Custom Assay Development include 2BScientific, PerkinElmer, Eurofins Discovery, Thermo Fisher Scientific, Creative Biolabs, PlexBio, Gyros Protein Technologies, Mission Bio and Sygnature Discovery, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Custom Assay Development market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Custom Assay Development.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Custom Assay Development Market by Company
2BScientific
PerkinElmer
Eurofins Discovery
Thermo Fisher Scientific
Creative Biolabs
PlexBio
Gyros Protein Technologies
Mission Bio
Sygnature Discovery
AssayGate
Charles River Laboratories
Promega Corporation
ProteoGenix
R&D Systems
Luminex
Eremid Genomic Services
INDIGO Biosciences
Cellomatics Biosciences
Camtech
SynVivo
Custom Assay Development Segment by Type
Assay Development
Assay Optimization
Assay Conversion
New Analyte Development
Custom Coupling
Custom Conjugation
Sample Testing
Other
Custom Assay Development Segment by Application
Medicine
Biology
Environment
Academic
Others
Custom Assay Development Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Assay Development market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Assay Development and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Assay Development.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Custom Assay Development companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Assay Development
- Assay Optimization
- Assay Conversion
- New Analyte Development
- Custom Coupling
- Custom Conjugation
- Sample Testing
- Other
Applications
- Medicine
- Biology
- Environment
- Academic
- Others
Companies covered
- 2BScientific
- PerkinElmer
- Eurofins Discovery
- Thermo Fisher Scientific
- Creative Biolabs
- PlexBio
- Gyros Protein Technologies
- Mission Bio
- Sygnature Discovery
- AssayGate
- Charles River Laboratories
- Promega Corporation
- ProteoGenix
- R&D Systems
- Luminex
- Eremid Genomic Services
- INDIGO Biosciences
- Cellomatics Biosciences
- Camtech
- SynVivo
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Custom Assay Development by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Assay Development
- 2.2.3 Assay Optimization
- 2.2.4 Assay Conversion
- 2.2.5 New Analyte Development
- 2.2.6 Custom Coupling
- 2.2.7 Custom Conjugation
- 2.2.8 Sample Testing
- 2.2.9 Other
- 2.3 Custom Assay Development by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medicine
- 2.3.3 Biology
- 2.3.4 Environment
- 2.3.5 Academic
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Custom Assay Development Breakdown Data by Type
- 3.1 Global Custom Assay Development Historic Market Size by Type (2021-2026)
- 3.2 Global Custom Assay Development Forecasted Market Size by Type (2027-2032)
4 Custom Assay Development Breakdown Data by Application
- 4.1 Global Custom Assay Development Historic Market Size by Application (2021-2026)
- 4.2 Global Custom Assay Development Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Custom Assay Development Market Perspective (2021-2032)
- 5.2 Global Custom Assay Development Growth Trends by Region
- 5.2.1 Global Custom Assay Development Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Custom Assay Development Historic Market Size by Region (2021-2026)
- 5.2.3 Custom Assay Development Forecasted Market Size by Region (2027-2032)
- 5.3 Custom Assay Development Market Dynamics
- 5.3.1 Custom Assay Development Industry Trends
- 5.3.2 Custom Assay Development Market Drivers
- 5.3.3 Custom Assay Development Market Challenges
- 5.3.4 Custom Assay Development Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Custom Assay Development Players by Revenue
- 6.1.1 Global Top Custom Assay Development Players by Revenue (2021-2026)
- 6.1.2 Global Custom Assay Development Revenue Market Share by Players (2021-2026)
- 6.2 Global Custom Assay Development Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Custom Assay Development Head Office and Area Served
- 6.4 Global Custom Assay Development Players, Product Type & Application
- 6.5 Global Custom Assay Development Manufacturers Established Date
- 6.6 Global Custom Assay Development Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Custom Assay Development Market Size (2021-2032)
- 7.2 North America Custom Assay Development Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Custom Assay Development Market Size by Country (2021-2026)
- 7.4 North America Custom Assay Development Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Custom Assay Development Market Size (2021-2032)
- 8.2 Europe Custom Assay Development Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Custom Assay Development Market Size by Country (2021-2026)
- 8.4 Europe Custom Assay Development Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Custom Assay Development Market Size (2021-2032)
- 9.2 Asia-Pacific Custom Assay Development Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Custom Assay Development Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Custom Assay Development Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Custom Assay Development Market Size (2021-2032)
- 10.2 South America Custom Assay Development Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Custom Assay Development Market Size by Country (2021-2026)
- 10.4 South America Custom Assay Development Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Custom Assay Development Market Size (2021-2032)
- 11.2 Middle East & Africa Custom Assay Development Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Custom Assay Development Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Custom Assay Development Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 2BScientific
- 12.1.1 2BScientific Company Information
- 12.1.2 2BScientific Business Overview
- 12.1.3 2BScientific Revenue in Custom Assay Development Business (2021-2026)
- 12.1.4 2BScientific Custom Assay Development Product Portfolio
- 12.1.5 2BScientific Recent Developments
- 12.2 PerkinElmer
- 12.2.1 PerkinElmer Company Information
- 12.2.2 PerkinElmer Business Overview
- 12.2.3 PerkinElmer Revenue in Custom Assay Development Business (2021-2026)
- 12.2.4 PerkinElmer Custom Assay Development Product Portfolio
- 12.2.5 PerkinElmer Recent Developments
- 12.3 Eurofins Discovery
- 12.3.1 Eurofins Discovery Company Information
- 12.3.2 Eurofins Discovery Business Overview
- 12.3.3 Eurofins Discovery Revenue in Custom Assay Development Business (2021-2026)
- 12.3.4 Eurofins Discovery Custom Assay Development Product Portfolio
- 12.3.5 Eurofins Discovery Recent Developments
- 12.4 Thermo Fisher Scientific
- 12.4.1 Thermo Fisher Scientific Company Information
- 12.4.2 Thermo Fisher Scientific Business Overview
- 12.4.3 Thermo Fisher Scientific Revenue in Custom Assay Development Business (2021-2026)
- 12.4.4 Thermo Fisher Scientific Custom Assay Development Product Portfolio
- 12.4.5 Thermo Fisher Scientific Recent Developments
- 12.5 Creative Biolabs
- 12.5.1 Creative Biolabs Company Information
- 12.5.2 Creative Biolabs Business Overview
- 12.5.3 Creative Biolabs Revenue in Custom Assay Development Business (2021-2026)
- 12.5.4 Creative Biolabs Custom Assay Development Product Portfolio
- 12.5.5 Creative Biolabs Recent Developments
- 12.6 PlexBio
- 12.6.1 PlexBio Company Information
- 12.6.2 PlexBio Business Overview
- 12.6.3 PlexBio Revenue in Custom Assay Development Business (2021-2026)
- 12.6.4 PlexBio Custom Assay Development Product Portfolio
- 12.6.5 PlexBio Recent Developments
- 12.7 Gyros Protein Technologies
- 12.7.1 Gyros Protein Technologies Company Information
- 12.7.2 Gyros Protein Technologies Business Overview
- 12.7.3 Gyros Protein Technologies Revenue in Custom Assay Development Business (2021-2026)
- 12.7.4 Gyros Protein Technologies Custom Assay Development Product Portfolio
- 12.7.5 Gyros Protein Technologies Recent Developments
- 12.8 Mission Bio
- 12.8.1 Mission Bio Company Information
- 12.8.2 Mission Bio Business Overview
- 12.8.3 Mission Bio Revenue in Custom Assay Development Business (2021-2026)
- 12.8.4 Mission Bio Custom Assay Development Product Portfolio
- 12.8.5 Mission Bio Recent Developments
- 12.9 Sygnature Discovery
- 12.9.1 Sygnature Discovery Company Information
- 12.9.2 Sygnature Discovery Business Overview
- 12.9.3 Sygnature Discovery Revenue in Custom Assay Development Business (2021-2026)
- 12.9.4 Sygnature Discovery Custom Assay Development Product Portfolio
- 12.9.5 Sygnature Discovery Recent Developments
- 12.10 AssayGate
- 12.10.1 AssayGate Company Information
- 12.10.2 AssayGate Business Overview
- 12.10.3 AssayGate Revenue in Custom Assay Development Business (2021-2026)
- 12.10.4 AssayGate Custom Assay Development Product Portfolio
- 12.10.5 AssayGate Recent Developments
- 12.11 Charles River Laboratories
- 12.11.1 Charles River Laboratories Company Information
- 12.11.2 Charles River Laboratories Business Overview
- 12.11.3 Charles River Laboratories Revenue in Custom Assay Development Business (2021-2026)
- 12.11.4 Charles River Laboratories Custom Assay Development Product Portfolio
- 12.11.5 Charles River Laboratories Recent Developments
- 12.12 Promega Corporation
- 12.12.1 Promega Corporation Company Information
- 12.12.2 Promega Corporation Business Overview
- 12.12.3 Promega Corporation Revenue in Custom Assay Development Business (2021-2026)
- 12.12.4 Promega Corporation Custom Assay Development Product Portfolio
- 12.12.5 Promega Corporation Recent Developments
- 12.13 ProteoGenix
- 12.13.1 ProteoGenix Company Information
- 12.13.2 ProteoGenix Business Overview
- 12.13.3 ProteoGenix Revenue in Custom Assay Development Business (2021-2026)
- 12.13.4 ProteoGenix Custom Assay Development Product Portfolio
- 12.13.5 ProteoGenix Recent Developments
- 12.14 R&D Systems
- 12.14.1 R&D Systems Company Information
- 12.14.2 R&D Systems Business Overview
- 12.14.3 R&D Systems Revenue in Custom Assay Development Business (2021-2026)
- 12.14.4 R&D Systems Custom Assay Development Product Portfolio
- 12.14.5 R&D Systems Recent Developments
- 12.15 Luminex
- 12.15.1 Luminex Company Information
- 12.15.2 Luminex Business Overview
- 12.15.3 Luminex Revenue in Custom Assay Development Business (2021-2026)
- 12.15.4 Luminex Custom Assay Development Product Portfolio
- 12.15.5 Luminex Recent Developments
- 12.16 Eremid Genomic Services
- 12.16.1 Eremid Genomic Services Company Information
- 12.16.2 Eremid Genomic Services Business Overview
- 12.16.3 Eremid Genomic Services Revenue in Custom Assay Development Business (2021-2026)
- 12.16.4 Eremid Genomic Services Custom Assay Development Product Portfolio
- 12.16.5 Eremid Genomic Services Recent Developments
- 12.17 INDIGO Biosciences
- 12.17.1 INDIGO Biosciences Company Information
- 12.17.2 INDIGO Biosciences Business Overview
- 12.17.3 INDIGO Biosciences Revenue in Custom Assay Development Business (2021-2026)
- 12.17.4 INDIGO Biosciences Custom Assay Development Product Portfolio
- 12.17.5 INDIGO Biosciences Recent Developments
- 12.18 Cellomatics Biosciences
- 12.18.1 Cellomatics Biosciences Company Information
- 12.18.2 Cellomatics Biosciences Business Overview
- 12.18.3 Cellomatics Biosciences Revenue in Custom Assay Development Business (2021-2026)
- 12.18.4 Cellomatics Biosciences Custom Assay Development Product Portfolio
- 12.18.5 Cellomatics Biosciences Recent Developments
- 12.19 Camtech
- 12.19.1 Camtech Company Information
- 12.19.2 Camtech Business Overview
- 12.19.3 Camtech Revenue in Custom Assay Development Business (2021-2026)
- 12.19.4 Camtech Custom Assay Development Product Portfolio
- 12.19.5 Camtech Recent Developments
- 12.20 SynVivo
- 12.20.1 SynVivo Company Information
- 12.20.2 SynVivo Business Overview
- 12.20.3 SynVivo Revenue in Custom Assay Development Business (2021-2026)
- 12.20.4 SynVivo Custom Assay Development Product Portfolio
- 12.20.5 SynVivo Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst